Award
National Institute of Allergy and Infectious Diseases 5R44AI181154-03
Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)
Recipient
NANOPATHDX, INC.
Award Amount
$919,857.00
Ceiling
$919,857.00
Awarded
August 04, 2026
Identifier
5R44AI181154-03
Award to NANOPATHDX, INC. for developing a rapid molecular diagnostic assay for urinary tract infections to enable targeted therapy and reduce antibiotic resistance.
Description
Development of a point-of-care molecular diagnostic to identify UTI-causing pathogens and key genetic markers of antibiotic resistance directly from a patient urine sample in 15 minutes without nucleic acid amplification. The project aims to expand the assay panel, optimize cartridge design, perform analytical verification, and evaluate clinical performance in a pilot study.